LLY Donald A Zakrowski sells $474K worth of shares
Jan 03, 2026, 5:37 PM
0.00%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
Donald A Zakrowski sold 3,700 shares of LLY on 2 March at $128.00 per share, worth a total of $474K. They now own 4,740 LLY shares, or a 44% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.